Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
39,75 USD | +4,61% | +18,91% | -13,11% |
26/04 | Belite Bio onthult plan om 651.380 American Depository Shares aan te bieden | MT |
22/03 | Belite Bio rondt reglementaire indiening af voor klinische studie met Tinlarebant in Japan | MT |
Omzet 2024 * | 10 mln. 9,35 mln. | Omzet 2025 * | 6,25 mln. 5,85 mln. | Marktkapitalisatie | 1,16 mld. 1,08 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -22 mln. -20,58 mln. | Nettowinst (verlies) 2025 * | -25 mln. -23,38 mln. | EV/omzet 2024 * | 110 x |
Nettoliquiditeiten 2024 * | 63,14 mln. 59,06 mln. | Nettoliquiditeiten 2025 * | 40,52 mln. 37,9 mln. | EV/omzet 2025 * | 179 x |
K/w-verhouding 2024 * |
-51,9
x | K/w-verhouding 2025 * |
-48,3
x | Werknemers | 20 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 19,31% |
Recentste transcriptie over Belite Bio, Inc
1 dag | +4,61% | ||
1 week | +18,91% | ||
Lopende maand | +3,60% | ||
1 maand | -8,58% | ||
3 maanden | -12,83% | ||
6 maanden | +3,79% | ||
Lopend jaar | -13,11% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yue Hsin Lin
CEO | Chief Executive Officer | 46 | 27-03-18 |
Hao Yuan Chuang
DFI | Director of Finance/CFO | 40 | 01-11-20 |
Nathan L. Mata
CTO | Chief Tech/Sci/R&D Officer | 58 | 01-11-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 72 | 01-04-22 | |
Yi Ta Lue
BRD | Director/Board Member | 47 | 01-04-22 |
John Longo
BRD | Director/Board Member | 55 | 01-04-22 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 117 M€ | +1,11% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 39,75 | +4,61% | 46 599 |
25-04-24 | 38 | +1,96% | 16 035 |
24-04-24 | 37,27 | +0,73% | 32 733 |
23-04-24 | 37 | +7,31% | 38 820 |
22-04-24 | 34,48 | +3,14% | 9 447 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-13,11% | 1,16 mld. | |
+1,51% | 42,75 mld. | |
+8,57% | 41,34 mld. | |
+49,22% | 41,61 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |